If you're planning a pregnancy while on Wegovy, Zepbound, Ozempic, or Mounjaro, the direct answer is this: FDA labeling calls for stopping semaglutide medications at least 2 months before a planned pregnancy and tirzepatide medications at least 1 month before, and neither drug class is recommended during pregnancy or while trying to conceive without a structured taper plan.
TL;DR
- GLP-1 medications pregnancy safety means stopping Wegovy or Ozempic at least 2 months before conception per FDA labeling.
- Zepbound and Mounjaro (tirzepatide) carry a shorter 1-month washout window before a planned pregnancy: plan, don't guess.
- Compounded semaglutide has no verified dosing data for a pregnancy taper in 2026: skip it entirely, brand-only is the rule.
- A pre-conception Biomarker Audit catches thyroid and hormone shifts a taper can trigger: build the plan with a clinician, not a calendar app.
Why This Matters
Weight, hormones, and fertility are not separate systems. A GLP-1 medication that's actively slowing gastric emptying and shifting insulin sensitivity is also touching the hormonal signaling that governs ovulation, which is exactly why pregnancy planning on these drugs needs a real timeline instead of a guess.
STEP-1 trial data on semaglutide showed roughly 15% average weight loss, and SURMOUNT-1 data on tirzepatide showed up to roughly 22.5%, individual results vary. Neither trial included pregnant participants, and animal studies for both drug classes showed reproductive risk at doses relevant to human exposure. That's the entire reason the labels build in a washout window before conception rather than a same-day stop.
The Cardiometabolic Optimization Membership exists for exactly this kind of decision: one that touches metabolic, hormonal, and reproductive health at once, and needs a clinician reading the labs, not a generic taper schedule pulled off a forum.
What You'll Need
- A licensed clinician who will actually build a taper calendar with you, not just tell you to stop
- Your current medication name, dose, and injection or pill schedule in writing
- A target conception window, even a rough one ("trying within 6 months")
- Baseline labs: HbA1c, a full hormone panel, and thyroid markers, drawn before you make changes
- A folate/prenatal vitamin plan started before the taper, not after a positive test
- A written restart plan for after delivery or after breastfeeding ends, if you intend to resume
The Steps
1. Book the conversation before you skip a dose
Don't stop a GLP-1 medication cold on your own timeline. Call your clinician the same week you start actively planning, because the 2-month semaglutide window and 1-month tirzepatide window both start counting from your last dose, not from your due date. Skipping this step is the single most common mistake: patients stop mid-cycle out of caution, then find themselves in a 6-week gap with no monitoring and no plan.
2. Confirm exactly which molecule you're on
Zepbound and Mounjaro are both tirzepatide, just routed differently (cash-pay versus insurance-covered diabetes care), and they share the same 1-month washout guidance. Wegovy and Ozempic are both semaglutide and share the 2-month window. If you're not sure which molecule is in your pen, check the box or your pharmacy records before you set a date, since the two washout windows are different by a full month.
3. Set a discontinuation date on the calendar, not "soon"
Work backward from your target conception window. If you're hoping to conceive in month 6 of trying, your semaglutide stop date needs to land by month 4 at the latest, and your tirzepatide stop date by month 5. Write the actual date down with your clinician; a vague plan to "stop when we start trying" is how patients end up conceiving mid-taper.
4. Track what happens to your cycle after the last dose
GLP-1 therapy can affect menstrual regularity in some patients, and cycles can shift again once the medication clears. Log cycle length and any ovulation signs (basal temperature, ovulation predictor kits) for at least 2 cycles after your last dose so your clinician has real data, not a memory of "it felt normal." For the mechanism behind this, see how semaglutide affects fertility and menstrual cycles.
5. Run a pre-conception Biomarker Audit
A comprehensive panel covering ApoB, Lp(a), hs-CRP, HbA1c, and full hormone and thyroid markers tells you whether the metabolic gains from the medication are holding without it, and whether thyroid function needs adjustment before pregnancy. This is the panel GoodLife Health includes every 90 days inside the flat membership fee; expect it to shift some numbers back toward baseline once the medication clears, which is normal and exactly why the labs matter more than the scale in this window.
6. Rebuild the nutrition and muscle habits the medication was doing for you
GLP-1 medications suppress appetite; once that effect fades during the taper, hunger often returns before your habits catch up. Prioritize protein intake and continue resistance training through the taper so the metabolic gains don't reverse faster than your labs can track. Common mistake here: patients treat the taper as "off the hook" and let both nutrition and activity slide in the same 6 to 8 week window their appetite is coming back.
Troubleshooting
You conceived while still on the medication. Stop the medication and contact your clinician immediately; do not wait for your next scheduled visit. This is a call-your-doctor-today situation, not a wait-and-see one.
Your cycle hasn't returned to normal 8 weeks after your last dose. This isn't automatically alarming, but it's worth a hormone panel rather than another month of waiting, since untreated thyroid or ovulatory issues can be missed if you assume it's "just the medication wearing off."
You're regaining weight fast during the taper and it's affecting your motivation to keep the plan. Some regain is expected once appetite suppression fades; the labs, not the scale, are what determine whether your metabolic markers are holding. Recheck ApoB and HbA1c rather than reacting to a week of scale movement.
You want to switch from Ozempic to a shorter-washout option before trying to conceive sooner. This is a real conversation to have with a clinician, but switching molecules to shortcut the washout window without medical guidance defeats the purpose of the window in the first place.
You're breastfeeding and want to know when you can restart. Data on GLP-1 exposure through breast milk is limited, and restart timing should be an individual clinical decision, not a fixed rule. See GLP-1 for weight loss while breastfeeding for what that conversation typically covers.
Tools and Resources
- A written taper calendar from your clinician, dated against your conception window
- A pre-conception Biomarker Audit, covering hormone, thyroid, and metabolic markers
- A prenatal vitamin with folate, started before the taper begins
- A cycle-tracking method (app or basal temperature log) for at least 2 cycles post-taper
- Comparative background on the medications themselves: best GLP-1 medications for weight loss in 2026
One flat fee covers the doctor relationship and the labs; the medication itself is billed at pharmacy cost with zero markup, which matters here because a taper plan sometimes means a dose adjustment, not just a stop date, and that shouldn't come with a repricing surprise.
What To Do Next
If you're actively trying to conceive within the next 12 months and currently on a GLP-1 medication, the next move is a conversation, not a Google search for "how long before pregnancy." Board-certified physicians of Beluga Health, P.A., working under GoodLife Health's clinical protocols, build the taper date against your actual labs and your actual timeline. For the broader picture of what that first conversation looks like, read concierge medicine for pregnancy and prenatal care.
FAQ
Can you take Wegovy while trying to get pregnant?
No. FDA labeling for Wegovy (semaglutide) recommends discontinuing at least 2 months before a planned pregnancy, and the medication is not recommended during active attempts to conceive without that washout period.
How long before pregnancy should you stop Ozempic?
Ozempic is semaglutide, the same molecule as Wegovy, so the same 2-month discontinuation window before a planned pregnancy applies per FDA labeling as of 2026.
Is compounded semaglutide safe during pregnancy planning?
No compounded GLP-1 product, including compounded semaglutide, has FDA-approved dosing or safety data for any use, let alone pregnancy planning. Brand-only medications like Wegovy and Ozempic, prescribed and tapered by a clinician, are the only route with labeled guidance.
Does Zepbound affect fertility or menstrual cycles?
Zepbound (tirzepatide) can affect cycle regularity in some patients while active, similar to other GLP-1 medications, and the FDA label recommends stopping at least 1 month before a planned pregnancy to allow clearance before conception.
What happens if you get pregnant while on a GLP-1 medication?
Contact your clinician immediately and stop the medication; this is not a wait-for-your-next-appointment situation. Your clinician will review your labs and pregnancy timeline directly rather than following a generic protocol.
Can you restart a GLP-1 medication after breastfeeding?
Restart timing after breastfeeding is an individual clinical decision, since data on GLP-1 exposure through breast milk remains limited in 2026. This is a conversation for your clinician, not a fixed calendar rule.
How much does GLP-1 pregnancy planning care cost?
Membership-based clinical planning for a GLP-1 taper runs a flat $299 per month after a two-month, $598 initial commitment, with the medication itself billed separately at pharmacy cost with no markup. Pricing outside a flat-fee model varies and often adds dose-based fees as therapy changes.
Do GLP-1 medications affect egg quality or ovulation?
There's no clinical data confirming a direct effect on egg quality, but GLP-1 medications can influence ovulatory cycle regularity while active through weight and insulin-sensitivity changes. That's part of why labs and cycle tracking matter more than assumptions during a pre-conception taper.
One Last Thing
Semaglutide's half-life is roughly one week, which means it takes about 5 weeks for the drug to fully clear a typical patient's system, yet the FDA label still calls for a 2-month window. That extra month isn't about clearance, it's a safety margin built around the earliest weeks of organ development, which is exactly the period a pregnancy test often hasn't caught yet.
Related Guides
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/